...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: No mention of efficacy again...

Bear there was a planned futility analysis for "aducanumab".

This explains it.

https://www.ctvnews.ca/health/neurologist-optimistic-about-alzheimer-s-treatment-despite-halted-trials-1.4354310

Koo

Share
New Message
Please login to post a reply